NASDAQ:ACT Enact (ACT) Price, Holdings, & News $37.59 -0.66 (-1.73%) As of 12:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Enact (NASDAQ:ACT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Enact alerts:Sign Up Key Stats Today's Range$37.56▼$38.5250-Day Range$34.25▼$38.2552-Week Range$30.79▼$38.55Volume68,915 shsAverage Volume407,348 shsMarket Capitalization$5.54 billionAssets Under Management$12.40 millionDividend Yield2.23%Net Expense Ratio0.75%Aggregate RatingN/A ETF Overview Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. It engages in writing and assuming residential mortgage guaranty insurance. The company also offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; contract underwriting services for mortgage lenders; and mortgage-related reinsurance products. It primarily serves originators of residential mortgage loans. The company was formerly known as Genworth Mortgage Holdings, Inc. and changed its name to Enact Holdings, Inc. in May 2021. Enact Holdings, Inc. was founded in 1981 and is headquartered in Raleigh, North Carolina. Enact Holdings, Inc. operates as a subsidiary of Genworth Holdings Inc. Read More Enact ExpensesTypeACTTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.60%0.57%0.56%0.54%0.53%Other Expenses0.31%0.57%0.56%0.52%0.56%Total Expense0.91%0.74%0.76%0.73%0.73%Fee Waiver-0.16%-0.76%-0.66%-0.50%-0.63%Net Expense0.75%0.60%0.63%0.63%0.60% Receive ACT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enact and its competitors with MarketBeat's FREE daily newsletter. Email Address ACT ETF News HeadlinesLegislature overrides governor's veto to enact controversial law: 'An awful turning point'August 15 at 6:10 AM | msn.comShelter at full capacity, forced to enact rescue freezeAugust 14 at 8:08 PM | msn.comTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.August 15 at 2:00 AM | Porter & Company (Ad)Wash Post editorial sees possible short term success in Trump's decision to send National Guard to DCAugust 13 at 9:37 AM | msn.comMarcos urges Congress to 'swiftly enact' P6.793-T 2026 budget | INQTodayAugust 13 at 9:37 AM | msn.comBessent Calls for Fed to Enact ‘Series of Rate Cuts’August 13 at 9:37 AM | barrons.comSee More Headlines ACT ETF - Frequently Asked Questions How have ACT shares performed this year? Enact's stock was trading at $32.38 at the beginning of the year. Since then, ACT shares have increased by 16.1% and is now trading at $37.59. How were Enact's earnings last quarter? Enact Holdings, Inc. (NASDAQ:ACT) released its earnings results on Wednesday, July, 30th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The firm earned $304.89 million during the quarter, compared to analysts' expectations of $307.54 million. Enact had a net margin of 55.35% and a trailing twelve-month return on equity of 13.61%. Read the conference call transcript. Is Enact buying back stock? Enact's Board of Directors approved a stock repurchase plan on Wednesday, April 30th 2025, which permits the company to repurchase $350,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 6.5% of its shares through open market purchases. Shares buyback plans are often an indication that the company's management believes its stock is undervalued. When did Enact IPO? Enact (ACT) raised $253 million in an initial public offering (IPO) on Thursday, September 16th 2021. The company issued 13,310,400 shares at a price of $19.00 per share. Who are Enact's major shareholders? Enact's top institutional investors include Arrowstreet Capital Limited Partnership (0.78%), Geode Capital Management LLC (0.59%), First Trust Advisors LP (0.52%) and Allianz Asset Management GmbH (0.51%). Insiders that own company stock include Genworth Holdings, Inc, Rohit Gupta, Brian Gould and James Mcmullen. View institutional ownership trends. How do I buy shares of Enact? Shares of ACT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Enact own? Based on aggregate information from My MarketBeat watchlists, some other companies that Enact investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), ServiceNow (NOW) and e.l.f. Beauty (ELF). Fund Details IssuerAdvisorShares Fund NameAdvisorShares Vice ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:ACT Inception Date12/12/2017 Fund ManagerDan S. Ahrens, Robert M. Parker Webnew.mortgageinsurance.genworth.com Phone919-846-4100Fund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelDeveloped Markets RegionNorth America Number of Holdings0 Fund Statistics Assets Under Management$12.40 million Average Daily Volume$1.65 thousand Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorAdvisorShares Investments, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares147,510,000Beta0.57 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report ACT Sector ExposureACT Industry Exposure This page (NASDAQ:ACT) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enact Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enact With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.